169
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

SMILES-Based QSAR and Molecular Docking Study of Oseltamivir Derivatives as Influenza Inhibitors

, ORCID Icon, , &
Pages 3257-3277 | Received 22 Sep 2021, Accepted 08 Apr 2022, Published online: 23 Apr 2022
 

Abstract

The quantitative structure–activity relationship studies for the modeling the activity of 72 oseltamivir derivatives as influenza neuraminidase (H1N1) inhibitors are performed using the Monte Carlo method based on the target function involving index of ideality of correlation (IIC). The optimal descriptors based on the combination of SMILES and hydrogen suppressor graphs (HSG) are employed for the model construction. Internal and external validation confirms robustness and good predictive power of the generated QSAR models. Identification of the activity-enhancing attributes indicates the positive impact of nitrogen and double bond on the influenza inhibitory activity. Finally, the pIC50 of the twelve new oseltamivir derivatives from ChEMBL database were predicted based on the proposed model. The new compounds showed high predicted pIC50 values and their molecular docking study was also investigated.

Acknowledgments

The authors would like to express their deepest gratitude to Dr. Alla P. Toropova and Dr. Andrey A. Toropov for providing the CORAL software.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.